Wellington Management Group’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-22,395
Closed -$627K 2253
2022
Q1
$627K Hold
22,395
﹤0.01% 1842
2021
Q4
$612K Hold
22,395
﹤0.01% 1913
2021
Q3
$609K Buy
+22,395
New +$554K ﹤0.01% 1880
2020
Q1
Sell
-1,165,317
Closed -$29M 2110
2019
Q4
$29M Sell
1,165,317
-47,996
-4% -$973K 0.01% 892
2019
Q3
$20.6M Buy
1,213,313
+153,937
+15% +$2.8M ﹤0.01% 952
2019
Q2
$24.1M Sell
1,059,376
-558,771
-35% -$15.1M 0.01% 963
2019
Q1
$52M Sell
1,618,147
-1,390,715
-46% -$43M 0.01% 720
2018
Q4
$84.8M Sell
3,008,862
-60,110
-2% -$1.76M 0.02% 558
2018
Q3
$88.2M Buy
3,068,972
+102,059
+3% +$3.07M 0.02% 618
2018
Q2
$111M Sell
2,966,913
-148,467
-5% -$5.83M 0.02% 545
2018
Q1
$122M Sell
3,115,380
-37,178
-1% -$1.36M 0.03% 512
2017
Q4
$102M Buy
3,152,558
+35,723
+1% +$1.07M 0.02% 564
2017
Q3
$97.1M Buy
3,116,835
+535,174
+21% +$15.8M 0.02% 552
2017
Q2
$72.2M Sell
2,581,661
-339,351
-12% -$7.68M 0.02% 619
2017
Q1
$50.1M Buy
2,921,012
+10,683
+0.4% +$150K 0.01% 723
2016
Q4
$35.2M Sell
2,910,329
-996,050
-25% -$12.9M 0.01% 818
2016
Q3
$61.9M Sell
3,906,379
-27,218
-0.7% -$410K 0.02% 632
2016
Q2
$50.9M Buy
3,933,597
+551,206
+16% +$8.63M 0.01% 674
2016
Q1
$64.3M Sell
3,382,391
-139,930
-4% -$2.53M 0.02% 602
2015
Q4
$79.3M Buy
3,522,321
+1,900,742
+117% +$37.6M 0.02% 543
2015
Q3
$37.9M Buy
1,621,579
+624,967
+63% +$17.2M 0.01% 767
2015
Q2
$28.5M Buy
996,612
+232,873
+30% +$6.1M 0.01% 893
2015
Q1
$19.7M Sell
763,739
-46,832
-6% -$1.07M 0.01% 1045
2014
Q4
$15M Sell
810,571
-258,677
-24% -$4.65M ﹤0.01% 1125
2014
Q3
$16.6M Buy
+1,069,248
New +$16.1M ﹤0.01% 1084

Wellington Management Group's XENT Position: Q2 2022 in Review

Wellington Management Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 22,395 shares — an estimated $627K sold.

Wellington Management Group first reported a position in XENT in Q3 2014 and held it in 25 quarters. The position peaked at $122M in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Wellington Management Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Wellington Management Group sold 22,395 Intersect ENT, Inc shares in Q2 2022, an estimated $627K.
  • Wellington Management Group first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 25 quarters.
  • Wellington Management Group's Intersect ENT, Inc position peaked at $122M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.